Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 October 2021 | Story Dr Nitha Ramnath | Photo Rhona Klopper
Donating masks to Rekopane Primary School, were from the left: Alfi Moolman (UFS Directorate: Community Engagement), Sonja Venter-Botes (Bloemshelter), Tina Moleko (Rankwe Primary School), and Michelle Engelbrecht (UFS Centre for Health Systems Research and Development).


The Centre for Health Systems Research and Development (CHSR&D) at the University of the Free State (UFS) recently donated 500 masks to Rekopane Primary School in Botshabelo. This initiative was part of its pledge to donate 100 cloth masks to a previously disadvantaged primary school for every 1 000 of the first 5 000 completed questionnaires that formed part of a study survey examining people’s understanding of information about COVID-19 vaccines. The results of the study will be shared with stakeholders who are responsible for providing information about COVID-19 vaccinations.

It is known that a large number of people globally and in South Africa prefer not to be vaccinated. “There are many reasons for this, and we would like to find out where people are getting information about the COVID-19 vaccination, and whether they are able to understand this information, so that they can make an informed choice about getting vaccinated. We did this by asking people about their own health and COVID-19, where they have heard about the vaccine, if they understood this information, and whether they have had/would have the vaccine or not, as well as the reasons for this,” said Prof Michelle Engelbrecht, Director of CHSR&D. 

While following guidelines such as wearing masks, sanitising hands, and social distancing are important to prevent the spread of COVID-19, a large percentage of the population will need to be vaccinated if we want to control the pandemic in the long term and prevent hospitalisation and severe illness. 

All persons in South Africa aged 18 and older were invited to complete an online survey regarding their perceptions of COVID-19 vaccines. The survey, which was available in the seven most spoken languages in the country, was advertised on social media platforms such as Facebook and Twitter, and on the Moya app.  The survey was open from 1 to 31 September 2021, and the CHSR&D received 10 554 completed questionnaires.  No data was required to complete the survey.

The Department of Basic Education partners decided on the school that would benefit, and the study provided an opportunity to support Bloemshelter, a UFS flagship programme. Alfi Moolman of the Directorate: Community Engagement said that “NGOs are really struggling to make ends meet, and we are delighted that Bloemshelter could provide the masks as one of their income-generating projects.  So many lives are touched for the good. The university is indeed a caring organisation.”


News Archive

Researcher shares platform with Nobel Laureate at conference on nanomedicine
2013-01-10

Prof. Lodewyk Kock at the Everest viewpoint with Mount Everest behind him.
10 January 2013

Profs. Lodewyk Kock and Robert Bragg from the Department of Microbial, Biochemical and Food Biotechnology at the University of the Free State (UFS) both presented lectures at the first International Conference on Infectious Diseases and Nanomedicine that was held in Kathmandu, Nepal, late last year.

At the conference, also attended by senior representatives from the International Union of Microbiological Societies (IUMS), Prof. Kock delivered one of the two opening lectures, titled: Introducing New Nanotechnologies to Infectious Diseases (the other opening lecture was presented by Nobel Laureate, Prof. Barry J. Marshal). Prof. Kock also participated in the farewell address.

In two excellent lectures, Prof. Bragg spoke on Bacteriophages as potential treatment option of antibiotic-resistant bacteria, and on Bacterial resistance to quaternary ammonium compounds.

For Prof. Kock this very first conference on infectious diseases and nanomedicine was followed by a very exciting yeast research excursion through the Mount Everest Highway which winds through the villages of the Sherpa tribe.

He describes his journey: “The Mount Everest Highway is a rough road stretching through hills and glacial moraines of unfamiliar altitudes and cold temperatures. Throughout the journey I had to take care of not contracting altitude sickness which causes severe headaches and dizziness.

“The only way of transport is on foot, on long-haired cattle called Yaks, donkeys and by helicopter. After flying by plane from Kathmandu (the capital of Nepal), I landed at Lukla, regarded as the most dangerous airport in the world due to its short elevated runway and mountainous surroundings. From Lukla, the land of the Sherpa, I walked (trekked) with my Sherpa guide and porter (carrier) along the Everest Highway surrounded by various Buddhist Mani scripture stands, other Buddhist representations and many spectacular snow-tipped mountains of more than 6 000 m above sea level. Of these, the majestic mountain called Ama Dablam (6 812 m), the grand 8 516 m high peak of Lhotse and to its left the renowned Mount Everest at 8 848 m in height, caught my attention.

“Dwarfed by these mountain peaks on the horizon, I passed various villages until I eventually reached the beautiful village called Namche Bazar, the heart of the Khumbu region and hometown of the Sherpa. This took three days of up to six hours walking per day, while I spent the nights at the villages of Phakding and Monjo. From there I walked along the Dudh Kosi River which stretches towards Mount Everest, until I reached the high altitude Everest viewpoint – the end of my journey, after which I trekked back to Lukla to return to Kathmandu and South Africa.

“This expedition is the first exploration to determine the presence of yeasts in the Everest region. Results from this excursion will be used in collaborative projects with local universities in Nepal that are interested in yeast research.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept